DR Horton Inc (DHI)
Official siteCONSUMER CYCLICAL • RESIDENTIAL CONSTRUCTION • NYSE
Market Cap: $39.51B
Last updated: Nov 17, 2026 at 11:04 AM ET
DR Horton Inc (DHI) Stock Forecast
Analysts expect DR Horton (DHI) to earn $8.80 per share in the fiscal year ending Sep 30, 2027, on revenue of $31.32B. Of 21 analysts, 4 rate the stock Buy or Strong Buy, 15 Hold and 2 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Sep 30, 2027 were revised up and 12 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 21 ratings average 2.95, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 19% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 4 | 19.0% |
| Hold | 15 | 71.4% |
| Sell | 1 | 4.8% |
| Strong Sell | 1 | 4.8% |
- Consensus
- Hold
- Total analysts
- 21
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 25.1% and revenue estimates rise 5.9%.
- Fiscal year ending Sep 30, 2027
- $8.80
- EPS consensus, revenue $31.32B
- Fiscal year ending Sep 30, 2028
- $11.01
- EPS consensus, revenue $33.18B
- Next report
- Jan 18, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Sep 30, 2027 | $8.80 | $7.57 to $12.10 | 17 | $31.32B | $30.19B to $34.55B | 16 |
| Sep 30, 2028 | $11.01 | $8.35 to $15.76 | 14 | $33.18B | $30.37B to $39.57B | 13 |
Quarterly Estimates
The EPS consensus rises from $1.28 for the quarter ending Dec 31, 2026 to $1.84 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.28 | $1.17 to $1.45 | 15 | $6.08B | $5.90B to $6.32B | 14 |
| Mar 31, 2027 | $1.84 | $1.53 to $2.21 | 15 | $7.33B | $6.83B to $8.04B | 13 |
Estimate Revisions
Across the 4 periods below, the last 30 days brought 0 upward and 29 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Sep 30, 2027 | 0 | 12 |
| Fiscal year ending Sep 30, 2028 | 0 | 5 |
| Quarter ending Dec 31, 2026 | 0 | 6 |
| Quarter ending Mar 31, 2027 | 0 | 6 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has fallen 24.7% from $11.69.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Sep 30, 2027 | $8.80 | $9.94 | $11.45 | $11.69 | $11.69 | -24.7% |
| Fiscal year ending Sep 30, 2028 | $11.01 | $13.45 | $13.80 | $13.93 | $13.93 | -21.0% |
| Quarter ending Dec 31, 2026 | $1.28 | $2.08 | $2.20 | $2.23 | $2.23 | -42.6% |
| Quarter ending Mar 31, 2027 | $1.84 | $2.39 | $2.44 | $2.46 | $2.46 | -25.4% |
Frequently Asked Questions About DHI
What is the DHI stock forecast?
Consensus analyst estimates put DR Horton's EPS at $8.80 for the fiscal year ending Sep 30, 2027, on revenue of $31.32B. The consensus rating from 21 analysts is Hold.
How do analysts rate DHI stock?
Of 21 analysts covering DR Horton, 0 rate it Strong Buy, 4 Buy, 15 Hold, 1 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from DHI next year?
For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is $8.80, with estimates from $7.57 to $12.10 from 17 analysts. For the fiscal year ending Sep 30, 2028, the consensus EPS estimate is $11.01, with estimates from $8.35 to $15.76 from 14 analysts.
What revenue do analysts expect from DR Horton next year?
For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $31.32B, with estimates from $30.19B to $34.55B. For the fiscal year ending Sep 30, 2028, the consensus revenue estimate is $33.18B, with estimates from $30.37B to $39.57B.
How many analysts cover DHI?
21 analysts rate DR Horton stock, and 17 analysts estimate its EPS for the fiscal year ending Sep 30, 2027.
DHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors